Medicine pricing agreement will double annual growth in cost of branded drugs sold to the NHS
Under the 'Voluntary scheme for branded medicines pricing, access and growth', the annual allowed rate of growth in sales will rise to 4% by 2027.…
Published: 20 November 2023